GSA Capital Partners’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

GSA Capital Partners’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-261,898	Closed	-$191K	–	2120
2026 Q1	$191K	Buy	+261,898	New	+$1.19M	0.01%	1468
2023 Q4	–	Sell	-3,509	Closed	-$342K	–	1866
2023 Q3	$342K	Buy	3,509 +2,563	+271%	+$239K	0.03%	1008
2023 Q2	$111K	Buy	+946	New	+$120K	0.01%	1371

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

GSA Capital Partners's RVPH Position: Q2 2026 in Review

GSA Capital Partners sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 261,898 shares — an estimated $191K sold.

GSA Capital Partners first reported a position in RVPH in Q2 2023 and held it in 3 quarters. The position peaked at $342K in Q3 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

GSA Capital Partners reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
GSA Capital Partners sold 261,898 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $191K.
GSA Capital Partners first reported a position in REVIVA PHARMA HLDGS INC in Q2 2023 and held it in 3 quarters.
GSA Capital Partners's REVIVA PHARMA HLDGS INC position peaked at $342K in Q3 2023.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.